Indian Journal of Pathology and Microbiology
Home About us Instructions Submission Subscribe Advertise Contact e-Alerts Ahead Of Print Login 
Users Online: 2405
Print this page  Email this page Bookmark this page Small font sizeDefault font sizeIncrease font size

    Article Cited by others

ORIGINAL ARTICLE

Utility of lytic bacteriophage in the treatment of multidrug-resistant Pseudomonas aeruginosa septicemia in mice

Vinodkumar C S, Kalsurmath Suneeta, Neelagund Y F

Year : 2008| Volume: 51| Issue : 3 | Page no: 360-366

   This article has been cited by
 
1 Limitations of Phage Therapy and Corresponding Optimization Strategies: A Review
Jiaxi Lin, Fangyuan Du, Miao Long, Peng Li
Molecules. 2022; 27(6): 1857
[Pubmed]  [Google Scholar] [DOI]
2 Parallel evolution of Pseudomonas aeruginosa phage resistance and virulence loss in response to phage treatment in vivo and in vitro
Meaghan Castledine, Daniel Padfield, Pawel Sierocinski, Jesica Soria Pascual, Adam Hughes, Lotta Mškinen, Ville-Petri Friman, Jean-Paul Pirnay, Maya Merabishvili, Daniel de Vos, Angus Buckling
eLife. 2022; 11
[Pubmed]  [Google Scholar] [DOI]
3 Bacteriophage Therapy of Bacterial Infections: The Rediscovered Frontier
Nejat DŁzgŁnes, Melike Sessevmez, Metin Yildirim
Pharmaceuticals. 2021; 14(1): 34
[Pubmed]  [Google Scholar] [DOI]
4 Pharmacokinetics and Pharmacodynamics of a Novel Virulent Klebsiella Phage Kp_Pokalde_002 in a Mouse Model
Gunaraj Dhungana, Roshan Nepal, Madhav Regmi, Rajani Malla
Frontiers in Cellular and Infection Microbiology. 2021; 11
[Pubmed]  [Google Scholar] [DOI]
5 Characteristics of a Bacteriophage, vB_Kox_ZX8, Isolated From Clinical Klebsiella oxytoca and Its Therapeutic Effect on Mice Bacteremia
Ping Li, Yangheng Zhang, Fuhua Yan, Xin Zhou
Frontiers in Microbiology. 2021; 12
[Pubmed]  [Google Scholar] [DOI]
6 Phages and their lysins: Toolkits in the battle against foodborne pathogens in the postantibiotic era
Zhenhua Huang, Zhaohuan Zhang, Jinrong Tong, Pradeep K. Malakar, Liangbiao Chen, Haiquan Liu, Yingjie Pan, Yong Zhao
Comprehensive Reviews in Food Science and Food Safety. 2021; 20(4): 3319
[Pubmed]  [Google Scholar] [DOI]
7 Phage therapeutics: from promises to practices and prospectives
Kanika Bhargava, Gopal Nath, Amit Bhargava, G. K. Aseri, Neelam Jain
Applied Microbiology and Biotechnology. 2021;
[Pubmed]  [Google Scholar] [DOI]
8 Temporal succession of water microbiomes and resistomes during carcass decomposition in a fish model
Rui Zhou, Yijie Wang, Mian Gul Hilal, Qiaoling Yu, Tianshu Feng, Huan Li
Journal of Hazardous Materials. 2021; 403: 123795
[Pubmed]  [Google Scholar] [DOI]
9 Isolation and characterization of a lytic bacteriophage against Pseudomonas aeruginosa
Sonika Sharma, Sibnarayan Datta, Soumya Chatterjee, Moumita Dutta, Jhuma Samanta, Mohan G. Vairale, Rajeev Gupta, Vijay Veer, Sanjai K. Dwivedi
Scientific Reports. 2021; 11(1)
[Pubmed]  [Google Scholar] [DOI]
10 Fabrication of gelatin/silk fibroin/phage nanofiber scaffold effective against multidrug resistant Pseudomonas aeruginosa
W. A. Sarhan, H. G. Salem, M. A. F. Khalil, I. M. El-Sherbiny, H. M. E. Azzazy
Drug Development and Industrial Pharmacy. 2021; 47(6): 947
[Pubmed]  [Google Scholar] [DOI]
11 New Phage cocktail against infantile Sepsis bacteria
Sadeq Abdulridha Gatea Kaabi, Hadeel Kareem Musafer
Microbial Pathogenesis. 2020; 148: 104447
[Pubmed]  [Google Scholar] [DOI]
12 Phage therapy efficacy: a review of the last 10 years of preclinical studies
LuŪs D. R. Melo, Hugo Oliveira, Diana P. Pires, Krystyna Dabrowska, Joana Azeredo
Critical Reviews in Microbiology. 2020; 46(1): 78
[Pubmed]  [Google Scholar] [DOI]
13 Cefoperazone sodium liposomal formulation to mitigate P. aeruginosa biofilm in Cystic fibrosis infection: A QbD approach
Vinod Ghodake, Jyoti Vishwakarma, Sirisha L. Vavilala, Vandana Patravale
International Journal of Pharmaceutics. 2020; 587: 119696
[Pubmed]  [Google Scholar] [DOI]
14 A Review on Basic Biology of Bacterial Biofilm Infections and Their Treatments by Nanotechnology-Based Approaches
Debjani Banerjee,P. M. Shivapriya,Pavan Kumar Gautam,Krishna Misra,Amaresh Kumar Sahoo,Sintu Kumar Samanta
Proceedings of the National Academy of Sciences, India Section B: Biological Sciences. 2019;
[Pubmed]  [Google Scholar] [DOI]
15 Explorative Study on Isolation and Characterization of a Microviridae G4 Bacteriophage, EMCL318, against Multi-Drug-resistant Escherichia coli 15-318
Soumya Ghosh,Emma Persad,Ting-Yun Shiue,Cindy Lam,Afsana Islam,Lauren Mascibroda,Michael Sherman,Thomas Smith,Naowarat Cheeptham
Antibiotics. 2018; 7(4): 92
[Pubmed]  [Google Scholar] [DOI]
16 Bacteriophages and phage products: Applications in medicine and biotechnological industries, and general concerns
Belay Mulugeta,Sisay Tesfaye,Wolde Tesfaye
Scientific Research and Essays. 2018; 13(6): 55
[Pubmed]  [Google Scholar] [DOI]
17 The Potential of Phage Therapy in Sepsis
Andrzej Gůrski,Ewa Jonczyk-Matysiak,Marzanna Lusiak-Szelachowska,Ryszard Miedzybrodzki,Beata Weber-Dabrowska,Jan Borysowski
Frontiers in Immunology. 2017; 8
[Pubmed]  [Google Scholar] [DOI]
18 Phage Inhibit Pathogen Dissemination by Targeting Bacterial Migrants in a Chronic Infection Model
Sophie E. Darch,Kasper N. Kragh,Evelyn A. Abbott,Thomas Bjarnsholt,James J. Bull,Marvin Whiteley,Vanessa Sperandio
mBio. 2017; 8(2)
[Pubmed]  [Google Scholar] [DOI]
19 Bacteriophages and their derivatives for the treatment and control of food-producing animal infections
Carla Carvalho,Ana Rita Costa,Filipe Silva,Ana Oliveira
Critical Reviews in Microbiology. 2017; 43(5): 583
[Pubmed]  [Google Scholar] [DOI]
20 Insights into Bacteriophage Application in Controlling Vibrio Species
Vengadesh Letchumanan,Kok-Gan Chan,Priyia Pusparajah,Surasak Saokaew,Acharaporn Duangjai,Bey-Hing Goh,Nurul-Syakima Ab Mutalib,Learn-Han Lee
Frontiers in Microbiology. 2016; 7
[Pubmed]  [Google Scholar] [DOI]
21 The role of antimicrobials in the treatment of sepsis and critical illness-related bacterial infections: Examination of the evidence
Iain Keir,Amy E. Dickinson
Journal of Veterinary Emergency and Critical Care. 2015; : n/a
[Pubmed]  [Google Scholar] [DOI]
22 Bacteriophage Delivery by Nebulization and Efficacy Against Phenotypically Diverse Pseudomonas aeruginosa from Cystic Fibrosis Patients
Jaspreet Singh Sahota,Claire Mary Smith,Priya Radhakrishnan,Craig Winstanley,Marina Goderdzishvili,Nina Chanishvili,Aras Kadioglu,Chris OśCallaghan,Martha Rebecca Jane Clokie
Journal of Aerosol Medicine and Pulmonary Drug Delivery. 2015; 28(5): 353
[Pubmed]  [Google Scholar] [DOI]
23 Ability of Bacteriophage in Resolving Wound Infection Caused by Multidrug-Resistant Acinetobacter baumannii in Uncontrolled Diabetic Rats
VinodKumar Chickmangalure Shivaswamy,Suneeta Basavaraj Kalasuramath,Chethan Kumar Sadanand,Abhishek Kilagere Basavaraju,Varsha Ginnavaram,Sumanth Bille,Sanjay Saju Ukken,Usha Nandini Pushparaj
Microbial Drug Resistance. 2015; 21(2): 171
[Pubmed]  [Google Scholar] [DOI]
24 A historical overview of bacteriophage therapy as an alternative to antibiotics for the treatment of bacterial pathogens
Xavier Wittebole,Sophie De Roock,Steven M Opal
Virulence. 2014; 5(1): 6
[Pubmed]  [Google Scholar] [DOI]
25 Bacteriophages and Their Derivatives as Biotherapeutic Agents in Disease Prevention and Treatment
Mohamed Elbreki,R. Paul Ross,Colin Hill,Jim OśMahony,Olivia McAuliffe,Aidan Coffey
Journal of Viruses. 2014; 2014: 1
[Pubmed]  [Google Scholar] [DOI]
26 Use of bacteriophages in the treatment ofPseudomonas aeruginosainfections
James Soothill
Expert Review of Anti-infective Therapy. 2013; 11(9): 909
[Pubmed]  [Google Scholar] [DOI]
27 Novel therapeutic strategies to counter <i>Pseudomonas aeruginosa</i> infections
Joanne L Fothergill, Craig Winstanley, Chloe E James
Expert Review of Anti-infective Therapy. 2012; 10(2): 219
[HTML Full text]  [Google Scholar] [DOI]
28 Bacteriophages for the treatment of Pseudomonas aeruginosa infections : Ps. aeruginosa phage therapy
D.R. Harper, M.C. Enright
Journal of Applied Microbiology. 2011; : no
[HTML Full text]  [Google Scholar] [DOI]
29 Phage therapy: delivering on the promise
DR Harper, J Anderson, MC Enright
Therapeutic Delivery. 2011; 2(7): 935
[HTML Full text]  [Google Scholar] [DOI]
30 Bacteriophage versus antimicrobial agents for the treatment of murine burn wound infection caused by Klebsiella pneumoniae B5055
S. Kumari, K. Harjai, S. Chhibber
Journal of Medical Microbiology. 2011; 60(2): 205
[HTML Full text]  [Google Scholar] [DOI]
31 Fighting bacterial infectionsóFuture treatment options
Jenny Fernebro
Drug Resistance Updates. 2011; 14(2): 125
[HTML Full text]  [Google Scholar] [DOI]
32 In silico analysis of Ardmore, a novel mycobacteriophage isolated from soil
Marine Henry,Orla OśSullivan,Roy D. Sleator,Aidan Coffey,R. Paul Ross,Olivia McAuliffe,Jim M. OśMahony
Gene. 2010; 453(1-2): 9
[Pubmed]  [Google Scholar] [DOI]
33 In silico analysis of Ardmore, a novel mycobacteriophage isolated from soil
Henry, M., OśSullivan, O., Sleator, R.D., Coffey, A., Ross, R.P., McAuliffe, O., OśMahony, J.M.
Gene. 2010; 453((1-2)): 9-23
[Pubmed]  [Google Scholar]
34 Bacteriophages and phage therapy | [Bakteriofagi i fagoterapia]
Gryko, R., Parasion, S., Mizak, L.
Medycyna Weterynaryjna. 2010; 66(4): 232-235
[Pubmed]  [Google Scholar]
35 The perspectives of the application of phage therapy in chronic bacterial prostatitis : Phage therapy in chronic bacterial prostatitis
Sławomir Letkiewicz, Ryszard Międzybrodzki, Marlena Kłak, Ewa Jończyk, Beata Weber-Dąbrowska, Andrzej Gůrski
FEMS Immunology & Medical Microbiology. 2010; 60(2): 99
[HTML Full text]  [Google Scholar] [DOI]
36 Bacteriophage and their lysins for elimination of infectious bacteria
Sarah OśFlaherty,R. Paul Ross,Aidan Coffey
FEMS Microbiology Reviews. 2009; 33(4): 801
[Pubmed]  [Google Scholar] [DOI]
37 Bacteriophage and their lysins for elimination of infectious bacteria: Review article
OśFlaherty, S., Ross, R.P., Coffey, A.
FEMS Microbiology Reviews. 2009; 33(4): 801-819
[Pubmed]  [Google Scholar]

 

Read this article